The FDA has approved a new drug from Eli Lilly to help Americans lose weight: Zepbound. The drug is a new formula of the popular diabetes treatment Mounjaro and it joins other medications like Ozempic and Wegovy as weapons against obesity. Emergency medicine physician Dr. Owais Durrani joined CBS News to discuss the new drug and its potential side effects.
Source: CBS Minnesota
FDA approves weight loss drug Zepbound, joining Ozempic and Wegovy in market
Published in Fifty Lakes
More from Fifty LakesMore posts in Fifty Lakes »
- Airlines scramble to comply with FAA order cutting thousands of flights
- See how often flights have been delayed at major airports during the shutdown
- Senate GOP shuts down war powers resolution aimed at blocking Venezuela strikes
- Zohran Mamdani won by shaking up NYC politics
- Cowboys' Marshawn Kneeland died from self-inflicted gunshot wound, DPS says
Be First to Comment